BRR : 12322693
Click Here To View Tendering Authority. Technical Bid City/State :  Delhi, Delhi
Tender Brief : Tender for Supply Of Trivalent Seasonal Influenza Vaccine (Siv) For Haj Session 2027 , Seasonal Influenza Vaccine (Trivalent) (For Adults) Specification: As Per The Who Recommendations The Trivalent Vaccines For Use In The 2027 Influenza Season (Nh) Contain The Following: Egg-Based Vaccines • An A/Missouri/11/2025 (H1n1)Pdm09-Like Virus; • An A/Darwin/1454/2025 (H3n2)-Like Virus; And • A B/Tokyo/Eis13-175/2025 (B/Victoria Lineage)-Like Virus. Whichever Strain/S Is/Are Prevalent At The Time Of Placing Supply Order Will Be Incorporated Accordingly At Least ¾ Of The Shelf Life Should Be Availabl... Read More
Tender Value
₹ Ref. Document
Submission Date
19-10-2026
Participated Bidder List
2 No of Bidder(s)
Sr No. Bidder Name Bid Analytics Technical Bid Financial Bid AOC Bid Value Rank
1 cnet-technologies Bid Analytics
2 cnet-technologies Bid Analytics
Work Detail
tender for supply of trivalent seasonal influenza vaccine (siv) for haj session 2027 , seasonal influenza vaccine (trivalent) (for adults) specification: as per the who recommendations the trivalent vaccines for use in the 2027 influenza season (nh) contain the following: egg-based vaccines • an a/missouri/11/2025 (h1n1)pdm09-like virus; • an a/darwin/1454/2025 (h3n2)-like virus; and • a b/tokyo/eis13-175/2025 (b/victoria lineage)-like virus. whichever strain/s is/are prevalent at the time of placing supply order will be incorporated accordingly at least ¾ of the shelf life should be available at the time of delivery. minimum shelf life: 12 months , seasonal influenza vaccine (trivalent) (for adults) specification: as per the who recommendations the trivalent vaccines for use in the 2027 influenza season (nh) contain the following: egg-based vaccines • an a/missouri/11/2025 (h1n1)pdm09-like virus; • an a/darwin/1454/2025 (h3n2)-like virus; and • a b/tokyo/eis13-175/2025 (b/victoria lineage)-like virus. whichever strain/s is/are prevalent at the time of placing supply order will be incorporated accordingly at least ¾ of the shelf life should be available at the time of delivery. minimum shelf life: 12 months , seasonal influenza vaccine (trivalent) (for adults) specification: as per the who recommendations the trivalent vaccines for use in the 2027 influenza season (nh) contain the following: egg-based vaccines • an a/missouri/11/2025 (h1n1) pdm09-like virus; • an a/darwin/1454/2025 (h3n2)-like virus; and • a b/tokyo/eis13-175/2025 (b/victoria lineage)-like virus. whichever strain/s is/are prevalent at the time of placing supply order will be incorporated accordingly at least ¾ of the shelf life should be available at the time of delivery. minimum shelf life: 12 months , seasonal influenza vaccine (trivalent) (for adults) specification: as per the who recommendations the trivalent vaccines for use in the 2027 influenza season (nh) contain the following: cell culture-, recombinant protein - or nucleic acid based vaccines • an a/missouri/11/2025 (h1n1) pdm09-like virus; • an a/darwin/1415/2025 (h3n2)-like virus; and • a b/pennsylvania/14/2025 (b/victoria lineage)-like virus. whichever strain/s is/are prevalent at the time of placing supply order will be incorporated accordingly at least ¾ of the shelf life should be available at the time of delivery. minimum shelf life: 12 months , seasonal influenza vaccine (trivalent) (for adults) specification: as per the who recommendations the trivalent vaccines for use in the 2027 influenza season (nh) contain the following: cell- or recombinant protein - or nucleic acid based vaccines • an a/missouri/11/2025 (h1n1)pdm09-like virus; • an a/darwin/1415/2025 (h3n2)-like virus; and • a b/pennsylvania/14/2025 (b/victoria lineage)-like virus. whichever strain/s is/are prevalent at the time of placing supply order will be incorporated accordingly at least ¾ of the shelf life should be available at the time of delivery. minimum shelf life: 12 months , seasonal influenza vaccine (trivalent) (for adults) specification: as per the who recommendations the trivalent vaccines for use in the 2027 influenza season (nh) contain the following: cell culture-, recombinant protein - or nucleic acid based vaccines • an a/missouri/11/2025 (h1n1) pdm09-like virus; • an a/darwin/1415/2025 (h3n2)-like virus; and • a b/pennsylvania/14/2025 (b/victoria lineage)-like virus. whichever strain/s is/are prevalent at the time of placing supply order will be incorporated accordingly at least ¾ of the shelf life should be available at the time of delivery. minimum shelf life: 12 months
View Original Notice/Document
Result Documents
Tender Documents
Download File Name File Description
Download 6a6de5ea-6655-4d0e-bc7e-d9f0441be479 technicalevaluation notice
Download technical_974445 document
Download techsummary_974445 document
Download File Name File Description
Download 3ebc8e0b-c1e0-4f40-b3f5-6e9be6341662 Tender Documents
Download BOQ_974445 Tender Documents
Download sivtenderdocument2027 Tender Documents
Download Tendernotice_1 Tender Documents
Disclaimer

We takes all possible care for accurate & authentic tender information. However users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender

Technical Evaluation In Progress

Technical bid evaluation is currently in progress. Awarded bidder details will be available after completion of technical scrutiny.

TechnicalBid
Similar Tenders Results